GATC Buys Second 454 GS FLX System | GenomeWeb
NEW YORK (GenomeWeb News) – GATC Biotech has purchased a second Genome Sequencer FLX system from Roche’s 454 Life Sciences’ subsidiary, 454 announced today.
 
“Having two Genome Sequencer FLX Systems available enables us to execute very demanding sequencing projects on short notice and handle production peaks much better," Thomas Pohl, CTO of GATC, said in a statement. “For example, we are able to run one instrument with a paired-end application and the other one with single reads.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.